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Age-related disease, not aging per se, causes
most morbidity in older humans. Here we report
that skeletal muscle respiratory uncoupling due
to UCP1 expression diminishes age-related dis-
ease in three mouse models. In a longevity
study, median survival was increased in UCP
mice (animals with skeletal muscle-specific
UCP1 expression), and lymphomawasdetected
less frequently in UCP female mice. In apoE null
mice, a vascular disease model, diet-induced
atherosclerosis was decreased in UCP animals.
In agouti yellow mice, a genetic obesity model,
diabetes and hypertension were reversed by in-
duction of UCP1 in skeletal muscle. Uncoupled
mice had decreased adiposity, increased tem-
perature and metabolic rate, elevated muscle
SIRT and AMP kinase, and serum characterized
by increased adiponectin and decreased IGF-1
and fibrinogen. Accelerating metabolism in
skeletal muscle does not appear to impact ag-
ing but may delay age-related disease.
INTRODUCTION
Atherosclerosis, diabetes, hypertension, and cancer oc-
cur more frequently with increasing age. These age-
related diseases are distinct from the process of aging,
a postreproductive physiological decline that includes
decreases in muscle strength, cardiopulmonary function,
vision, and hearing as well as wrinkled skin and graying
hair. Aging and age-related disease are associated but
may not share the same mechanisms.
Disruption of insulin/IGF-1-like signaling prolongs life
span in nematodes (Kenyon et al., 1993) and flies (Tatar
et al., 2001). However, this issue is more complex in
mice, where life span is increased in females with inactiva-
tion of one allele of the IGF-1 receptor, but males have glu-
cose intolerance and survival is not significantly prolonged
(Holzenberger et al., 2003). Inactivation of the insulin
receptor in mouse adipose tissue increases life spanCell Met(Bluher et al., 2003), but its inactivation in mouse liver
causes diabetes (Michael et al., 2000), a disease that is
probably contributing to decreases in human life span
due to the current obesity epidemic (van Dam et al.,
2006; Adams et al., 2006). Aging is impressively delayed
in mutant mice with defects in anterior pituitary develop-
ment (Flurkey et al., 2001; Brown-Borg et al., 1996). The
opposite may occur in humans. Some investigators have
reported premature mortality due mostly to atherosclero-
sis in people with defects in pituitary function (Tomlinson
et al., 2001; Bates et al., 1996), although thismay not apply
to individuals with reduction of IGF-1 levels due to growth-
hormone resistance or isolated growth-hormone defi-
ciency (Laron, 2005; Oliveira et al., 2006).
In flies, JNK activation prolongs life span by antagoniz-
ing insulin signaling (Wang et al., 2005), but JNK activation
in mice promotes diabetes (Hirosumi et al., 2002) and ath-
erosclerosis (Ricci et al., 2004). Certain mutations that
increase the activity of the tumor suppressor p53 in mice
decrease cancer frequency but also accelerate aging
(Tyner et al., 2002), raising the possibility that disease sus-
ceptibility and life span may be independently modulated.
Given the difficulty of validating strategies to increase life
span in humans and the possible dissociation between
aging and age-related diseases, identifying a simple inter-
vention affecting several age-related diseases is an attrac-
tive approach to decreasing the morbidity of growing old.
Altering the efficiency of mitochondrial respiration, the
transfer of electrons from food to oxygen to synthesize
ATP, may represent such an intervention. Uncoupling pro-
teins (UCPs) are inner mitochondrial membrane anion
transporters that disrupt ATP synthesis, releasing heat
and causing a compensatory increase in oxygen con-
sumption. UCP1, the first such protein to be identified, is
responsible for heat production in brown fat. Transgenic
mice with the murineUCP1 cDNA driven by the rat myosin
light chain 2 promoter, which ectopically express UCP1 in
skeletal muscle, are protected from diet-induced (Li et al.,
2000) and genetic (Bernal-Mizrachi et al., 2002) obesity.
Overexpression of the related proteins UCP2 and UCP3
in mice also decreases obesity and improves insulin sen-
sitivity (Clapham et al., 2000; Horvath et al., 2003; Choi
et al., 2007). Less is known about the potential role of un-
coupling in other disorders as well as in overall survival,abolism 6, 497–505, December 2007 ª2007 Elsevier Inc. 497
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Skeletal Muscle Metabolism and AgingFigure 1. Increased Survival and Fewer Cancer Deaths in Mice with Respiratory Uncoupling in Skeletal Muscle
(A) Survival curves for UCP1 transgenic (UCP, solid red line) and wild-type (WT, dashed blue line) mice. The p value represents a comparison of
median survival. For comparison of curves by log-rank testing, p = 0.0262.
(B) Probable cause of death as determined by necropsy for all 104 animals in (A). The difference in lymphoma detection was gender based, with no
cases detected in UCP females and 8 cases detected in WT females (p = 0.0045 by Fisher’s exact test).
(C and D) Body weight (C) and adiposity (D) were determined over time for the animals in (A).
(E) Body temperature as determined by telemetry using implanted sensors in 3-month-old littermate mice not included in the longevity study (WT,
n = 6; UCP, n = 9; p = 0.0478 by two-tailed t test).
(F–J) Fasting free fatty acids (F), glucose (G), insulin (H), cholesterol (I), and triglycerides (J) were determined over time for the animals in (A).
Data are presented as mean ± SEM. *p < 0.05. Data are presented for males and females combined in this and subsequent figures; the same patterns
were seen when sexes were analyzed separated.although UCP2 null mice have increased susceptibility to
chemically induced colon tumors (Derdak et al., 2006).
Young animals with low-level expression of UCP1 in
skeletal muscle have a mildly increased metabolic rate,
normal food intake, normal growth, and normal levels of
ATP and phosphocreatine in muscle (Li et al., 2000). We
used these mice to determine whether respiratory uncou-
pling in skeletal muscle, a tissue that adapts to altered
heat production and oxygen consumption during exer-
cise, can affect age-related disease.
RESULTS AND DISCUSSION
Increased Survival in Uncoupled Mice
UCP1 transgenic mice were backcrossed five times with
C57BL/6 mice, and the resulting wild-type (WT) and litter-498 Cell Metabolism 6, 497–505, December 2007 ª2007 Elseviemate UCP1 transgenic (UCP) mice were provided free
access to standard chow diet until their natural death
(Figure 1A). Median survival was prolonged by 3 months
in the UCP mice (30 months for UCP versus 27 months
for WT; p = 0.0074 by Mann-Whitney test). Survival curves
were different by log-rank testing (p = 0.0262). Data repre-
sent both sexes; the same trends were seen in males and
females (see Figure S1 in the Supplemental Data available
with this article online). Maximal life spanwas not affected;
death occurred at 39 and 39.5months for the longest lived
WT and UCP mouse, respectively. Median survival for the
longest lived 20% of each group was 33 months for WT
mice and 35 months for UCP mice (p = 0.0753). Lym-
phoma, the most common probable cause of death
detected at necropsy in WT mice (Figure 1B), was less
frequent in UCP mice due to a gender-specific difference.r Inc.
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Skeletal Muscle Metabolism and AgingIn females, lymphoma was detected in 8 of 25WT and 0 of
22 UCP mice (p = 0.0045 by Fisher’s exact test). In males,
lymphoma was detected in 4 animals of each genotype.
UCPmice weighed less (Figure 1C) and had lower adipos-
ity (Figure 1D). Lower bodyweight in humans is associated
with lower risk for lymphoma (Pan et al., 2005), analogous
to our less frequent detection of lymphoma in UCP mice
(Figure 1B).
Young UCP animals had core body temperatures
0.5C higher than WT mice (Figure 1E), reflecting the
biochemical effect of uncoupling. Body temperature is
reduced in some long-lived mutant mice (Hunter et al.,
1999). Caloric restriction can decrease body temperature,
but mice engineered to maintain a lower body tempera-
ture (Conti et al., 2006) have a survival phenotype similar
to UCP mice with higher body temperature, suggesting
that lower temperature is not required to increase median
life span in the absence of caloric restriction. There were
minimal genotype differences in levels of fatty acids,
glucose, insulin, cholesterol, and triglycerides over time
between WT and UCP mice (Figures 1F–1J). UCP mice
had significantly increased metabolic rates compared to
WT mice, but there were no differences in food intake,
fecal fat, or caloric output in feces (Figure S2).
Separate cohorts of young (3 months) and old (>12
months) WT and UCP mice were further characterized
(Figure 2). Transgenic expression of UCP1 was sustained
with age. Western blots showed similar expression of
UCP1 in the skeletal muscle of young and old transgenic
mice (Figure 2A, right). Sir2 is anNAD-dependent deacety-
lase that mediates increased survival with caloric restric-
tion in other models. Its mammalian homolog SIRT1 has
been implicated in stress tolerance and several metabolic
pathways (Guarente, 2006). UCP skeletal muscle SIRT
enzyme activity was 2-fold higher than WT in young mice
and 4-fold higher in oldmice (Figure 2B, left panel). To con-
firm this finding, PGC-1aacetylationwasassayed in young
and old mice (Figure 2B, right panel; Figure S3). As ex-
pected, less acetylated PGC-1a protein was detected in
UCP skeletal muscle. SIRT induction was not systemic
since there were no differences in SIRT enzyme activity
between WT and UCP mice in liver, brain, heart, or spleen
(Figure S4).
A number of proteins may coordinate metabolism,
stress responses, and disease susceptibility. Two such
proteins, AMPK and mTOR, were reciprocally affected in
UCP skeletal muscle, with higher levels of phosphorylated
AMPK and lower levels of phosphorylated mTOR as
compared to WT (Figure 2C). This effect was not systemic
since these proteins were similarly activated in liver and
spleen of UCP and WT mice (data not shown). Activated
levels of another such protein, p53, were lower in UCP
as compared to WT animals in liver (Figure 2C), a site
remote from muscle, but were unaffected by genotype in
muscle itself or spleen (data not shown). We were unable
to detect differences between WT and UCP mice in tissue
levels of FoxO1/3a, HSP70, or HSP90 (data not shown).
As an unbiased approach to identify potential media-
tors of the delayed death phenotype of UCPmice, plasmaCell Meproteins were subjected to proteomic analysis (Figure 2D).
Multiple spots contained fibrinogen isoforms that were
less abundant in young and old UCP mice as compared
to WT mice. Complement C3 (row 13 in Figure 2D) also
appeared to be present at lower levels in the plasma of
young and old UCP mice. Both of these differences
were confirmed in separate cohorts of mice by ELISA.
Fibrinogen levels were 10% lower in UCP mice, consis-
tent with human epidemiologic studies identifying fibri-
nogen as a risk factor for nonvascular as well as vascu-
lar causes of mortality (Danesh et al., 2005). UCP mice
had 40% lower levels of C3, which is involved in many
inflammatory disorders and is highly correlated with both
fibrinogen and body mass index in humans (Capuano
et al., 2006).
Serum levels of IGF-1, adiponectin, and leptin were also
different in UCP mice (Figure 2F). Each may be related to
decreased adiposity. Interruption of IGF-1 signaling
increases life span in some animals (Holzenberger et al.,
2003), and IGF-1 signaling may predispose to malignancy
in humans and mice (LeRoith and Roberts, 2003). Con-
centrations of IGF-1 are decreased in humans with low
body mass (Gram et al., 2006), and IGF-1 levels were
also lower in UCP mice (Figure 2F). Adiponectin is higher
and leptin lower with decreased adiposity (Faraj et al.,
2003), the pattern seen in UCP mice (Figure 2F). Elevated
adiponectin has been associated with increased longevity
in other mouse studies (Wang et al., 2006).
Delayed Atherosclerosis in Uncoupled Mice
To determine whether skeletal muscle respiratory uncou-
pling has beneficial effects on atherosclerosis, UCP mice
were bred with apolipoprotein E-deficient (apoE/) mice.
When fed a ‘‘western-type’’ high-fat (HF) diet, these ani-
mals develop hyperlipidemia and atherosclerotic lesions
resembling those seen in early human vascular disease.
After 6 weeks of HF diet, en face assays of the aorta
showed less atherosclerosis in UCP apoE/ mice as
compared to WT apoE/ littermates (Figure 3A). After
12 weeks on the same HF diet, lesion extent in UCP
mice had increased to the same level as WT littermates
(data not shown), indicating that the presence of the
UCP transgene delayed but did not abolish disease.
UCP apoE/ and WT apoE/ mice had similar levels of
fasting cholesterol on a chow diet (Figure 3B, 0 weeks)
that increased to the same degree in both genotypes after
HF feeding (Figure 3B, 3 and 6 weeks), and there was no
genotype effect on cholesterol-containing lipoproteins
(Figure 3C), suggesting that changes in circulating choles-
terol, a major mediator of vascular injury, are not respon-
sible for the delayed development of atherosclerosis in
UCP mice.
As with C57BL/6 UCP mice in the survival study, body
weight (Figure 3D) was lower in chow-fed UCP apoE/
animals (Figure 3D, 0 weeks). Weight remained lower
with HF feeding (Figure 3D, 1.5, 3, and 6 weeks) in UCP
apoE/mice, likely because of their increased metabolic
rate (determined in a metabolic chamber; Figure S5).
There was no difference in fasting glucose betweentabolism 6, 497–505, December 2007 ª2007 Elsevier Inc. 499
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Skeletal Muscle Metabolism and AgingFigure 2. Biochemical Characteristics Associated with Increased Survival in Uncoupled Mice
(A) Levels of UCP1 protein as detected by western blotting. The first two lanes on the left were loaded with protein extracted from brown adipose
tissue (BAT). TheWTmuscle and UCPmuscle lanes were loaded with equal amounts of protein extracted from skeletal muscle of two different young
(3 months old) and old (>12 months old) mice.
(B) Left panel: SIRT enzyme activity in skeletal muscle from 12 youngWT, 12 young UCP, 5 oldWT, and 7 old UCPmice. Right panel: acetylated PCG-
1a levels normalized to total PCG-1a in 6 young WT, 6 young UCP, 6 old WT, and 6 old UCP mice.
(C) Levels of phosphorylated signaling molecules in skeletal muscle of youngWT and UCPmice. Phosphorylated AMPK, mTOR, and p53 levels were
determined by western blotting, normalized to total levels of the same proteins, and quantified by densitometry.
(D) Proteomic analysis of plasma from young and old WT and UCP mice. Age- and UCP-induced changes in plasma proteins were identified by two-
dimensional difference gel electrophoresis (2D-DIGE) image andmultivariate analysis. Proteins were identified using tandemmass spectrometry after
in situ gel digestions with trypsin. PZP, pregnancy zone protein; MUP, major urinary protein.
(E) Confirmation of differences for two proteins identified by proteomic analysis. Fibrinogen was assayed in 8 WT and 11 UCP mice (left panel), and
complement 3a was assayed in 4 WT and 4 UCP mice (right panel). AU, arbitrary units.
(F) Adiposity-related serum measurements in WT and UCP mice. IGF-1 was assayed in 25 WT and 28 UCP mice (left panel), adiponectin was mea-
sured in 25 WT and 30 UCP mice (middle panel), and leptin was assayed in 14 WT and 18 UCP mice (right panel).
Data are presented as mean ± SEM. *p < 0.05.genotypes on a chow diet (Figure 3E, 0 weeks), but fasting
glucose was lower (glycemic excursions in glucose toler-
ance tests were also lower; data not shown) in UCP
apoE/ animals fed a HF diet (Figure 3E, 3 and 6 weeks).
These metabolically beneficial differences in weight and
glucose are associated with decreased insulin resistance,
but whether these variables directly impact vascular dis-
ease is unknown. Other findings in UCP mice might ac-
count for delayed vascular disease. Like the animals in
the survival study, UCP apoE/ mice had lower levels500 Cell Metabolism 6, 497–505, December 2007 ª2007 Elsevierof IGF-1 (Figure 3F) and higher levels of adiponectin
(Figure 3G), differences that persisted over 6 weeks of
HF feeding. IGF-1 levels may predict vascular lesions in
humans (Hietaniemi et al., 2005), and transgenic expres-
sion of adiponectin decreases atherosclerosis in apoE/
mice (Yamauchi et al., 2003).
As an unbiased approach to identify potential mediators
of the delayed vascular disease phenotype of UCP mice,
proteomic multivariate analysis was used to identify differ-
entiating plasma proteins inWT apoE/ and UCP apoE/Inc.
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Skeletal Muscle Metabolism and AgingFigure 3. Delayed Diet-Induced Atherosclerosis Is Associated with Respiratory Uncoupling in apoE Null Mice
(A) UCP mice on the apoE null background were fed a ‘‘western-type’’ high-fat (HF) diet for 6 weeks, and atherosclerotic lesion extent was then de-
termined by en face analysis of the percent atherosclerotic involvement of the intimal surface of the aortic arch, thoracic aorta, and abdominal aorta
for 15 WT and 15 UCP littermates.
(B and C) Fasting cholesterol levels over time (B) and lipoprotein profiles at sacrifice (C) for the mice in (A).
(D and E) Body weight (D) and fasting glucose levels (E) over time for the mice in (A).
(F and G) IGF-1 (F) and adiponectin (G) levels for WT apoE null and UCP apoE null mice on a chow diet (time 0) and over 6 weeks of HF diet.
(H) Multivariate analysis of multiplex 2D-DIGE plasma protein images from WT apoE null and UCP apoE null mice on a chow diet (baseline) and after
1.5, 3, and 6 weeks of HF diet. Gel features that changed in pairwise comparisons of WT and UCP samples were analyzed using an unsupervised
hierarchical clustering algorithm in the Extended Data Analysis (EDA) module of DeCyder (v6.5). Clustering of plasma samples is shown in the top
tree, and clusters from the individual proteins are shown on the left.
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01.mice at baseline on a chow diet as well as at various time
points with HF feeding. An unsupervised hierarchical clus-
ter analysis of the proteins that showed significant differ-
ences (in relative abundance; p values are provided in Table
S1) for all pairwise comparisons between genotypes is pre-
sented in Figure 3H. Themajority of these proteinswere ex-
pressed at lower levels in UCP apoE/mice as compared
to WT apoE/mice, and these differences were amplified
with HF feeding. This is best seen by comparing the pre-
dominantly red profile (indicating increased protein levels)
of WT mice after 6 weeks on HF diet (far right column)
with the predominantly green profile (indicating lower pro-
tein levels) of UCPmice after the same intervention (secondCell Metcolumn from the left). Eight of the gel features identified by
mass spectrometry in Figure 3H represent components of
high-density lipoprotein (HDL) (apoAI, apoAII, apoAIV,
and hemopexin), and all were increased in WT as com-
pared to UCP mice. It is difficult to extrapolate cholesterol
data from mice to humans, given the striking differences
in lipid processing between these species and the fact
that the data are being derived from essentially herbivorous
animals fed a HF diet. However, HDL-associated proteins
have been reported to be increased in humans with vascu-
lar disease and present in human atherosclerotic lesions
(Vaisar et al., 2007), raising the possibility that certain
conditions (such as the chronic inflammation of HF feeding)abolism 6, 497–505, December 2007 ª2007 Elsevier Inc. 501
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Skeletal Muscle Metabolism and AgingFigure 4. Reversal of Increased Adiposity with Inducible Skeletal Muscle Uncoupling in Agouti YellowMice Lowers Blood Glucose
and Blood Pressure
(A) Ay/a genetically obese mice carrying two transgenes, a TRE-UCP1 minigene and a cassette consisting of the reverse tetracycline transactivator
driven by a modified creatine kinase promoter (MCK-rtTA), were implanted with placebo pellets (No Dox) or pellets designed to release doxycycline
(Dox) over a period of 21 days. Themeanweight of animals before randomization was 56.9 g (time 0). Data are presented as changes in weight relative
to baseline weight over time for 26 mice treated with Dox and 14 mice treated with placebo.
(B) Western blot of UCP1 protein in BAT (positive control, lane 1) and skeletal muscle 1 week after implantation of pellets containing placebo (tissues
from two separate animals in lanes 2 and 3) or Dox (tissues from two separate animals in lanes 4 and 5).
(C) Metabolic rate following induction of UCP expression in skeletal muscle.MCK-rtTA-TRE-UCP1 Ay/a animals were treated with placebo (7 males)
or doxycycline (8 males) using implanted pellets, and oxygen consumption was determined by indirect calorimetry.
(D) Adiposity for 10 Dox and 9 placebo animals at day 18.
(E) Food intake for 4 animals in each group at day 15.
(F) Lean body mass for 10 Dox and 9 placebo animals at day 18.
(G) Fasting plasma glucose at baseline (40 animals) and at days 18–21 for Dox-treated animals (26) and placebo-treated animals (14).
(H and I) Glucose tolerance tests at baseline (5 mice for Dox, 7 for placebo) (H) and at day 17 of treatment (6 mice per condition) (I), with results
presented as blood glucose concentrations.502 Cell Metabolism 6, 497–505, December 2007 ª2007 Elsevier Inc.
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Skeletal Muscle Metabolism and Agingrender HDL atherogenic. Our results suggest that respira-
tory uncoupling in skeletal muscle antagonizes these
effects.
Inducible Uncoupling Reverses Established
Metabolic Dysfunction
The beneficial effects of respiratory uncoupling on sur-
vival, cancer, and atherosclerosis (Figure 1, Figure 2,
and Figure 3) were seen in mice engineered to express
UCP1 in muscle throughout life. To determine whether it
is possible to reverse, as opposed to prevent, age-related
disease, we generated mice capable of tetracycline-
inducible expression of UCP1 in skeletal muscle using
the agouti yellow (Ay/a) model of genetic obesity. Mice in
the Ay/a background expressing the reverse tetracycline
transactivator (rtTA) driven by a modified muscle creatine
kinase promoter were crossedwith transgenic mice carry-
ing a TRE-UCP1 minigene. To induce skeletal muscle
UCP1 expression, 5-month-old MCK-rtTA-TRE-UCP1
Ay/a animals weighing over 50 g were implanted with
either doxycycline (Dox) pellets releasing 65 mg of drug
over 21 days or placebo pellets. We have previously
shown that Dox treatment alone does not affect glucose
metabolism or blood pressure in animals not engineered
to express UCP (Bernal-Mizrachi et al., 2005). Body
weights over the ensuing 35 days are shown in Figure 4A.
Weight decreased in Dox-implanted mice but continued
to increase in placebo-implanted mice. UCP1 protein
was detected in the skeletal muscle of Dox-implanted
mice (Figure 4B, lanes 4 and 5) and in brown adipose tis-
sue as a positive control (Figure 4B, lane 1), but not in the
skeletal muscle of placebo-implanted mice (Figure 4B,
lanes 2 and 3). Induction of UCP1 in skeletal muscle
increased metabolic rate (Figure 4C) and decreased adi-
posity (Figure 4D) but had no effect on food intake
(Figure 4E) or lean body weight (Figure 4F). This reduction
in adiposity was associated with and likely related to
decreased fasting blood glucose (Figure 4G). Before treat-
ment, both groups were glucose intolerant (Figure 4H),
a condition that was reversed by Dox induction of UCP1
(Figure 4I).
UCP1 induction in skeletal muscle by Dox treatment
also lowered blood pressure at two different time points
(Figure 4J), an effect that was reversed when treatment
was discontinued (Figure 4J, rightmost panel). Increased
adiposity is associated with sympathetic nervous system
activation and increased renal reabsorption of sodium
leading to hypertension. UCP1 induction increased uri-
nary sodium excretion (Figure 4K), likely by decreasing
sympathetic nervous system activation (reflected by de-
creased excretion of norepinephrine; Figure 4L). TheseCell Meresults in a genetic obesity model suggest that respira-
tory uncoupling in skeletal muscle can reverse, and not
simply prevent, abnormal glucose metabolism and blood
pressure.
Precedents for Beneficial Effects of Accelerating
Metabolism in Humans
Vulnerability to age-related disease may be governed in
part by pathways that respond to environmental depriva-
tion such as caloric restriction. Respiratory uncoupling in
muscle mimics nutritional deprivation as manifested by
increased SIRT activity and activation of AMPK in muscle,
decreased mTOR in muscle, decreased adipose tissue
mass, reduced serum IGF-1, and increased serum adipo-
nectin. Age-related diseases are characterized by chronic
inflammation, and adipose tissue recruits inflammatory
cells (Lumeng et al., 2007). In our mice, decreasing adi-
posity and inflammation by accelerating metabolism in
skeletal muscle delayed death and diseases including
malignancy, atherosclerosis, diabetes, and hypertension.
Our survival data, showing an increase in average life span
and no difference in maximal longevity, resemble the
results of exercise studies by Holloszy and colleagues in
male and female rats (Holloszy et al., 1985; Holloszy,
1993). Our results are also consistent with observational
studies showing that increased energy expenditure,
reflecting elevated skeletal muscle metabolism required
for physical activity, is associated with decreased mortal-
ity in healthy older humans (Manini et al., 2006). Respira-
tory uncoupling specifically in skeletal muscle may be
a particularly beneficial approach to increasing metabo-
lism. Expression of UCP3, a UCP1 homolog found in skel-
etal muscle, predicts diabetes in humans (Gable et al.,
2006; Schrauwen et al., 2006). Low levels of respiratory
uncoupling, analogous to those studied in our mice,
preserve mitochondrial function in aging human muscles
(Amara et al., 2007).
The consequences of excess adiposity disproportion-
ately affect older individuals. Excess adiposity can be
treated through two simple approaches, decreasing en-
ergy intake or increasing energy consumption. Consider-
able effort is currently being devoted to the development
of agents that decrease energy intake in hopes of
decreasing adiposity and perhaps age-related disease.
Our results indicate that increasing energy consumption
in mice has beneficial effects on survival, vascular
disease, elevated blood pressure, and diabetes. This in-
tervention does not slow aging but may diminish suscep-
tibility to pathology. Strategies to safely accelerate energy
consumption specifically in skeletal muscle could de-
crease the impact of some common age-related diseases.(J) Blood pressure at baseline (12 mice) and at varying time points during and after treatment (6 mice in each group). SBP, systolic blood pressure;
DBP, diastolic blood pressure.
(K and L) Urinary sodium excretion (24mice for Dox, 12 for placebo) (K) and urinary norepinephrine excretion (25mice for Dox, 12 for placebo) (L). Data
were derived from urine collections obtained over 3 days beginning at day 18 of treatment.
Data are presented as mean ± SEM. *p < 0.05.tabolism 6, 497–505, December 2007 ª2007 Elsevier Inc. 503
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Animals
Mice with ectopic expression of UCP1 limited to skeletal muscle were
generated by injecting C57BL/6 3 CBA hybrid embryos as described
previously (Li et al., 2000). Transgenic animals with low-level protein
expression (1% of brown fat) were backcrossed with inbred
C57BL/6 mice five times to yield animals used for the longevity exper-
iments. The same strategy was followed with apoE null mice on the
C57BL/6 background for the atherosclerosis experiments. Since the
animals used for the longevity and atherosclerosis experiments were
not on a homogeneous BL/6 background, all studies were performed
with littermates to decrease potential confounding effects of genetic
background. For the longevity studies, animals were weaned tomouse
chow at 3 weeks of age and group housed as described in other sur-
vival studies (Holzenberger et al., 2003). For studies involving weight
reduction, mice transgenic for a tetracycline-responsive element
(TRE) driving UCP1 gene expression (TRE-UCP1) (Bernal-Mizrachi
et al., 2005) were bred with Ay/amice. Mice expressing the reverse tet-
racycline transactivator (rtTA) controlled by amodifiedmuscle creatine
kinase promoter (1256[3Emut]MCK) (Grill et al., 2003) were also bred
with Ay/a mice. Appropriate progeny from these two crosses were
mated to generate doubly transgenic animals in the Ay/a model.
SIRT Activity and PGC-1a Acetylation Assays
Measurements were performed using a histone deacetylase assay kit
(Upstate) according to the manufacturer’s instructions. SIRT activity
was determined as the NAD-dependent and nicotinamide-inhibitable
ability of tissue extracts to deacetylate a fluorometric substrate. Re-
leased substrate was detected using a fluorescence plate reader.
Each experiment included an appropriate standard curve, and all
measurements were recorded within the linear response range of the
assay.
PGC-1a acetylation status was determined as described previously
(Rodgers et al., 2005). PGC-1a was immunoprecipitated from muscle
protein lysate using H-300 antibody (Santa Cruz), and these immuno-
precipitates were then western blotted using an anti-acetyl lysine anti-
body (Cell Signaling Technology) to detect acetylated PGC-1a. Total
PGC-1a in separate aliquots of these lysates was detected by western
blotting using H-300 antibody.
Protein Analyses
Samples for western blotting were resolved on 10%, 12%, or 4%–15%
SDS-polyacrylamide gels and transferred to nitrocellulose. Tissue han-
dling and ELISA details, antibody sources, and proteomics protocols,
including two-dimensional difference gel electrophoresis (2D-DIGE)
and gel featuremultivariate analyses, are listed in Supplemental Exper-
imental Procedures.
Atherosclerosis and Analytical Procedures
Atherosclerosis wasmeasured using the en face technique (Semenko-
vich et al., 1998). Blood pressure was measured as described previ-
ously (Bernal-Mizrachi et al., 2005). Other analytical procedures are
listed in Supplemental Experimental Procedures.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, five figures, and one table and can be found
with this article online at http://www.cellmetabolism.org/cgi/content/
full/6/6/497/DC1/.
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